The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: FearLess in Cognitively Intact Patients With Glioma
Official Title: FearLess in Cognitively Intact Patients With Glioma
Study ID: NCT05604365
Brief Summary: This study will assess the preliminary feasibility and acceptability of FearLess, a newly-developed psychological intervention for fear of cancer recurrence (FCR) among cognitively-intact patients with glioma.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Virginia Commonwealth University, Richmond, Virginia, United States
Name: Ashlee Loughan, PhD
Affiliation: Virginia Commonwealth University
Role: PRINCIPAL_INVESTIGATOR